Dr. Brunetta is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1600 Divisadero St
Dept Of Pulmonary & Critic
San Francisco, CA 94115
Education & Training
Tufts University School of MedicineClass of 1990
Certifications & Licensure
CA State Medical License 1992 - 2013
Clinical Trials
Publications & Presentations
PubMed
- 1694 citationsRituximab versus Cyclophosphamide for ANCA-Associated VasculitisJohn H. Stone, Peter A. Merkel, Robert Spiera, Philip Seo, Carol A. Langford
The New England Journal of Medicine. 2010-07-15 - 108 citationsRituximab Versus Cyclophosphamide for ANCA-Associated Vasculitis with Renal InvolvementDuvuru Geetha, Ulrich Specks, John H. Stone, Peter A. Merkel, Philip Seo
Journal of the American Society of Nephrology. 2015-04-01 - 912 citationsEfficacy and safety of rituximab in patients with active proliferative lupus nephritis: The lupus nephritis assessment with rituximab study†Brad H. Rovin, Richard Furie, Kevin Latinis, R. John Looney, Fernando C. Fervenza
Arthritis and Rheumatism. 2012-04-01
Journal Articles
- Peripheral Blood B Cell Depletion After Rituximab and Complete Response in Lupus NephritisMatthew D Cascino, Jay Garg, Paul Brunetta, Tamiko R Katsumoto, Paul Brakeman, Brad Rovin, Leonard Dragone, Richard John Looney, Journal of the American Society of Nephrology
Press Mentions
Backed by $700M, Startup Led by Vets of Genentech, UCSF, Juno Has Ambitious Cell and Gene Therapy GoalsJune 24th, 2020- Giving Highly Funded but Secretive Moderna a Run for Its Money, Juno-Lite Sana Raises $700MJune 23rd, 2020
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
